The Living Guidelines: UA/NSTEMI Recommendations for Warfarin Therapy Polling Results for CLASS IIb Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIb Guidelines

 * 1) Warfarin either without (INR 2.5 to 3.5) or with low-dose ASA (75 to 81 mg per d; INR 2.0 to 2.5) may be reasonable for patients at high CAD risk and low bleeding risk who do not require or are intolerant of clopidogrel. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIb Recommendation 1 for Inhibition of the Warfarin Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III